Nuclear pharmacy is a specialty area of pharmacy focused on preparing, compounding, and distributing radioactive drugs, called radiopharmaceuticals, for use in medical imaging and disease treatment. Unlike a traditional pharmacist who fills prescriptions for antibiotics or blood pressure medications and hands them directly to patients, a nuclear pharmacist prepares radioactive drugs and sends them to a hospital’s nuclear medicine department, where doctors and technicians administer them. It’s a small but fast-growing field sitting at the intersection of pharmacy, physics, and medicine.
What Nuclear Pharmacists Actually Do
The day-to-day work of a nuclear pharmacist revolves around radioactive materials. Core responsibilities include managing inventory of radioactive drugs and supplies, compounding and preparing radiopharmaceuticals to exact specifications, filling prescription orders from nuclear medicine providers, and checking equipment for quality and safety. Because these drugs contain radiation, nuclear pharmacists undergo extensive training in radiation safety that traditional pharmacists never need.
Most nuclear pharmacists work in centralized radiopharmacies that supply multiple hospitals, though some work inside large medical centers. Their hours often start very early in the morning. Many radiopharmaceuticals have extremely short shelf lives, measured in hours rather than days, so doses need to be prepared and delivered before the first patients arrive for scans. A drug compounded at 4 a.m. may lose half its radioactivity by mid-morning, making timing one of the most critical parts of the job.
How Radioactive Drugs Are Used in Medicine
Radiopharmaceuticals fall into two broad categories: diagnostic and therapeutic. Diagnostic radiopharmaceuticals are used for imaging. A patient receives a small amount of a radioactive tracer, and specialized cameras detect where it travels in the body. This approach powers two major imaging technologies: PET scans and SPECT scans. These scans can detect tumors, evaluate heart function, identify neurological disorders, and pinpoint areas of infection or inflammation with a level of detail that standard imaging sometimes can’t match.
Specific tracers are designed for specific targets. Some bind to proteins associated with prostate cancer, allowing doctors to see whether the disease has spread. Others cross into the brain and attach to abnormal protein clumps linked to Alzheimer’s disease. The tracer lights up wherever the target is, creating a functional map of disease activity rather than just a structural picture.
Therapeutic radiopharmaceuticals take a different approach. Instead of imaging, they deliver radiation directly to diseased tissue to destroy it. These drugs emit alpha or beta particles that damage cancer cells at close range while limiting harm to surrounding healthy tissue. This strategy is used to treat certain cancers, including advanced prostate cancer and thyroid conditions. The global radiopharmaceutical market was valued at roughly $7.75 billion in 2025 and is projected to more than double to nearly $18 billion by 2035, driven largely by expanding cancer treatment applications.
Inside a Hot Lab
Nuclear pharmacists work in specialized facilities called “hot labs,” designed specifically for handling radioactive materials. These labs look nothing like a retail pharmacy. The workspace is built around shielding, containment, and precise measurement.
Key equipment includes:
- Dose calibrators that measure the exact radiation dose of each preparation, ensuring it’s safe and accurate before it reaches a patient
- Shielded preparation stations where pharmacists compound radiopharmaceuticals behind lead or lead-glass barriers
- Well counters that provide sensitive radiation detection, helping prevent errors and verify compliance with safety standards
- Wipe test equipment used to check surfaces for radioactive contamination, keeping the working environment sterile and safe
- Shielded storage units that safely contain radioactive materials when they’re not in use
Everything in a hot lab is oriented around the fact that the products being handled emit radiation. Vials are stored in lead containers, syringes are placed in shielded carriers for transport, and every surface is routinely tested for contamination.
Radiation Safety and the ALARA Principle
The guiding philosophy of radiation safety in nuclear pharmacy is ALARA, which stands for “as low as reasonably achievable.” The idea is simple: even when doses are small, you avoid any radiation exposure that doesn’t serve a direct purpose. Nuclear pharmacists apply ALARA through three practical strategies.
The first is time. You minimize how long you spend near radioactive materials. Work quickly, then move away. The second is distance. Radiation intensity drops sharply as you move farther from the source, so even a few extra feet make a meaningful difference. The third is shielding. Placing dense material between you and the radiation source blocks or reduces exposure. Depending on the type of radiation, shielding can range from something as thin as a sheet of paper to several inches of lead.
Nuclear pharmacists also wear personal radiation detectors, sometimes called dosimeters, that track their accumulated exposure over time. These devices provide real-time alerts if radiation levels in a work area become elevated, helping workers manage how long they stay in any given spot. Facilities maintain detailed exposure records for every employee, ensuring no one exceeds established safety limits over the course of their career.
How Nuclear Pharmacy Is Regulated
Because radioactive drugs pose risks that conventional medications don’t, nuclear pharmacy falls under a layered regulatory system. At the federal level, the Nuclear Regulatory Commission (NRC) oversees the medical use of radioactive byproduct materials under Title 10 of the Code of Federal Regulations. The NRC licenses facilities, authorizes users, develops radiation safety rules, sets criteria for identifying errors in drug administration, requires prompt reporting of those errors, conducts inspections, and can impose fines for violations.
The FDA, meanwhile, regulates radiopharmaceuticals as drugs, meaning they must meet standards for safety and efficacy before they can be used clinically. State boards of pharmacy add another layer, governing the practice of pharmacy within their borders. In 29 states, known as “Agreement States,” the NRC formally delegates its authority to regulate radioactive materials to state governments. This means specific rules can vary depending on where a nuclear pharmacy operates, though the core safety standards remain consistent.
How to Become a Nuclear Pharmacist
Becoming a nuclear pharmacist starts with earning a Doctor of Pharmacy (Pharm.D.) degree, the same credential required for any pharmacist. From there, the path diverges. Aspiring nuclear pharmacists complete specialized training in radiopharmaceutical preparation, radiation physics, and radiation safety. This can happen through a dedicated residency program in nuclear pharmacy or through coursework and supervised experience that meets the requirements set by the NRC and state regulators.
Board certification is available through the Board of Pharmaceutical Specialties, which recognizes nuclear pharmacy as a distinct specialty. Certified nuclear pharmacists carry the credential BCNP (Board Certified Nuclear Pharmacist). The combination of pharmacy knowledge, radiation expertise, and regulatory training makes this one of the more technically demanding pharmacy specialties, but also one with strong job prospects as the radiopharmaceutical market continues to expand.